NCT04676477 · Interventional trial
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
Overall registry status Active not recruiting
Phase 1
Conditions Non-Small Cell Lung Cancer (NSCLC)
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory